Evrofarma (LTS:0EEK) Market Cap: €52.21 Mil (As of Jun. 25, 2026)


What is Evrofarma Market Cap?

Evrofarma LTS:0EEK Market Cap is €52.21 Mil as of Jun. 25, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Evrofarma's share price for the quarter that ended in . 20 was €. Evrofarma's Shares Outstanding (EOP) for the quarter that ended in . 20 was 0.00 Mil. Therefore, Evrofarma's market cap for the quarter that ended in . 20 was € Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Evrofarma's Enterprise Value for Today is €52.21 Mil.

Evrofarma  (LTS:0EEK) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Evrofarma Market Cap Related Terms

Evrofarma Market Cap Historical Data

* Premium members only.

The historical data trend for Evrofarma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evrofarma Market Cap Chart

Evrofarma Annual Data
Trend
Market Cap

Evrofarma Quarterly Data
Market Cap

LTS:0EEK vs FAMI, VATE, CYAN: Market Cap Comparison

For the Packaged Foods subindustry, Evrofarma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evrofarma Market Cap vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Evrofarma's Market Cap distribution charts can be found below:

* The bar in red indicates where Evrofarma's Market Cap falls into.


Evrofarma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Evrofarma's Market Cap for the fiscal year that ended in . 20 is calculated as

Market Cap (A: . 20 )=Share Price (A: . 20 )*Shares Outstanding (EOP) (A: . 20 )
=€*
=€

Evrofarma's Market Cap for the quarter that ended in . 20 is calculated as

Market Cap (Q: . 20 )=Share Price (Q: . 20 )*Shares Outstanding (EOP) (Q: . 20 )
=€*0
=€

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €52.21 Mil mean?
Evrofarma (LTS:0EEK) has a Market Cap of €52.21 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Evrofarma and its competitors.
Is Evrofarma's Market Cap too high?
Evrofarma's current Market Cap is €52.21 Mil.
How does Evrofarma's Market Cap compare to FAMI and VATE?
Evrofarma's Market Cap of €52.21 Mil can be compared against companies in the Consumer Packaged Goods industry. The industry median Market Cap is 101.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 101.90, based on 2,041 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Evrofarma and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 101.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evrofarma's current Market Cap is €52.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evrofarma stock overvalued right now?
Evrofarma (LTS:0EEK) has a current Market Cap of €52.21 Mil. The current Market Cap is €52.21 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Evrofarma (LTS:0EEK), the current Market Cap is €52.21 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evrofarma Business Description

Address 1st km Didimoticho-Orestiada, Didimoticho, GRC, 68300
Evrofarma SA through its subsidiary Campus SA produces milk and dairy products such as yogurt and cheese. The company also trades animal feed and animals such as cows, goats and sheep. Its products include Yellow Cheese, Anthotiro, Telemes, Cow's yogurt, Goat's cheese and Feta DPO.